Alzheimer's drug may also improve memory in down syndrome and normal ageing: Study - ETHealthWorld

3/31/2022 12:00:00 AM3 years 1 month ago
by ET HealthWorld
by ET HealthWorld
The drug sargramostim. GM-CSF, which stands for granulocyte-macrophage colony-stimulating factor, is the first to show memory improvement in Alzheimer's patients in phase II clinical trial. GM-CSF is a normal human protein that is safe and well-tolerated with…
Aurora: The results of the new study led by the University of ColoradoAnschutz Campus have found that GM-CSF, which is an Alzheimer's drug, may improve cognitive function in people with Down syndrome… [+2960 chars]
full article...